The glucocerobrosidase E326K variant predisposes to Parkinson's disease, but does not cause Gaucher's disease
Open Access
- 5 December 2012
- journal article
- research article
- Published by Wiley in Movement Disorders
- Vol. 28 (2), 232-236
- https://doi.org/10.1002/mds.25248
Abstract
Background Heterozygous loss-of-function mutations in the acid beta-glucocerebrosidase (GBA1) gene, responsible for the recessive lysosomal storage disorder, Gaucher's disease (GD), are the strongest known risk factor for Parkinson's disease (PD). Our aim was to assess the contribution of GBA1 mutations in a series of early-onset PD. Methods One hundred and eighty-five PD patients (with an onset age of ≤50) and 283 age-matched controls were screened for GBA1 mutations by Sanger sequencing. Results We show that the frequency of GBA1 mutations is much higher in this patient series than in typical late-onset patient cohorts. Furthermore, our results reveal that the most prevalent PD-associated GBA1 mutation is E326K, a variant that does not, when homozygous, cause GD. Conclusions Our results confirm recent reports that the mutation, E326K, predisposes to PD and suggest that, in addition to reduced GBA1 activity, other molecular mechanisms may contribute to the development of the disease. © 2012 Movement Disorder SocietyThis publication has 26 references indexed in Scilit:
- Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onsetNeurology, 2009
- Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control studyThe Lancet Neurology, 2008
- Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson diseaseNeurology, 2007
- Detection of 12 new mutations in Gaucher disease Brazilian patientsBlood Cells, Molecules, and Diseases, 2006
- Perinatal lethal phenotype with generalized ichthyosis in a type 2 Gaucher disease patient with the [L444P;E326K]/P182L genotype: Effect of the E326K change in neonatal and classic forms of the diseaseBlood Cells, Molecules, and Diseases, 2005
- Parkinsonism among Gaucher disease carriersJournal of Medical Genetics, 2004
- Functional analysis of 13GBAmutant alleles identified in Gaucher disease patients: Pathogenic changes and “modifier” polymorphismsHuman Mutation, 2004
- The E326K mutation and Gaucher disease: mutation or polymorphism?Clinical Genetics, 2002
- Non–pseudogene-derived complex acid β-glucosidase mutations causing mild type 1 and severe type 2 Gaucher diseaseJCI Insight, 1999
- Two new mild homozygous mutations in Gaucher disease patients: Clinical signs and biochemical analysesAmerican Journal of Medical Genetics, 1997